<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation creator="Hitomi MASUDA" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7864072"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7864072</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Effects of <term sem="Lipid" id="T1" lex="glucocorticoid">glucocorticoids</term> on <term sem="Other" id="T2" lex="transcription_factor_activation"><term sem="Protein_family_or_group" id="A1">transcription factor</term> activation</term> in <term sem="Cell_natural" id="T3" lex="human_peripheral_blood_mononuclear_cell">human peripheral blood mononuclear cells</term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="A1" />
<clue>Effects of glucocorticoids on transcription factor <clueType>activation</clueType> in human peripheral blood mononuclear cells.</clue>
</event>
<event id="E2">
<type class="Regulation" />
<theme idref="E1" />
<cause idref="T1" />
<clue><clueType>Effects</clueType> <linkCause>of</linkCause> glucocorticoids <linkTheme>on</linkTheme> transcription factor activation <clueLoc>in human peripheral blood mononuclear cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Lipid" id="T4" lex="glucocorticoid">Glucocorticoids</term> have an inhibitory effect on <cons sem="(AND Other Other)" id="T5" lex="(AND inflammatory_response immune_response)"><frag id="F1"><term sem="Other" id="A2">inflammatory</term></frag> and <term sem="Other" id="A3"><frag id="F2">immune</frag> <frag id="F3"><term sem="Other" id="A4">responses</term></frag></term></cons>, and this may be through the modulation of <term sem="Protein_family_or_group" id="T6" lex="transcription_factor">transcription factor</term> binding to <term sem="DNA_domain_or_region" id="A5">DNA</term>.</sentence>
<event id="E3">
<type class="Negative_regulation" />
<theme idref1="A4" idref="A2" />
<cause idref="T4" />
<clue>Glucocorticoids <clueType>have an inhibitory effect</clueType> <linkTheme>on</linkTheme> inflammatory and immune responses, and this may be through the modulation of transcription factor binding to DNA.</clue>
</event>
<event id="E4">
<type class="Negative_regulation" />
<theme idref="A3" />
<cause idref="T4" />
<clue>Glucocorticoids <clueType>have an inhibitory effect</clueType> <linkTheme>on</linkTheme> inflammatory and immune responses, and this may be through the modulation of transcription factor binding to DNA.</clue>
</event>
<event id="E5">
<type class="Binding" />
<theme idref="T6" />
<theme idref="A5" />
<clue>Glucocorticoids have an inhibitory effect on inflammatory and immune responses, and this may be through the modulation of transcription factor <clueType>binding</clueType> <linkTheme>to</linkTheme> DNA.</clue>
</event>
<event id="E6">
<type class="Regulation" />
<theme idref="E5" />
<clue>Glucocorticoids have an inhibitory effect on inflammatory and immune responses, and this may be through the <clueType>modulation</clueType> <linkTheme>of</linkTheme> transcription factor binding to DNA.</clue>
</event>
<event uncertainty="probable" id="E7">
<type class="Positive_regulation" />
<theme idref="E4" />
<cause idref="E6" />
<clue>Glucocorticoids have an inhibitory effect on inflammatory and immune responses, and <corefTheme>this</corefTheme> may be <linkCause>through</linkCause> the modulation of transcription factor binding to DNA.</clue>
<comment>No clueType</comment></event>
<event uncertainty="probable" id="E200">
<type class="Positive_regulation" />
<theme idref="E3" />
<cause idref="E6" />
<clue>Glucocorticoids have an inhibitory effect on inflammatory and immune responses, and <corefTheme>this</corefTheme> may be <linkCause>through</linkCause> the modulation of transcription factor binding to DNA.</clue>
<comment>No clueType</comment></event>
<sentence id="S3">The interaction of the <term sem="Protein_family_or_group" id="T7" lex="transcription_factor">transcription factors</term>, <term sem="Protein_molecule" id="T8" lex="activator_protein-1">activator protein-1</term> (<term sem="Protein_molecule" id="T9" lex="AP-1">AP-1</term>), <term sem="Protein_molecule" id="T10" lex="nuclear_factor_kappa_B">nuclear factor kappa B</term> (<term sem="Protein_molecule" id="T11" lex="NF_kappa_B">NF kappa B</term>), and <term sem="Protein_molecule" id="T12" lex="cAMP-responsive_element_binding_protein">cAMP-responsive element binding protein</term> (<term sem="Protein_molecule" id="T13" lex="CREB">CREB</term>) with <term sem="DNA_domain_or_region" id="A6">DNA</term> and <term sem="Protein_family_or_group" id="T14" lex="glucocorticoid_receptor">glucocorticoid receptors</term> (<term sem="Protein_family_or_group" id="T15" lex="GR">GR</term>) was analyzed in <term sem="Cell_natural" id="T16" lex="human_peripheral_blood_mononuclear_cell">human peripheral blood mononuclear cells</term> by <term sem="Other" id="T17" lex="gel_mobility_shift_assay">gel mobility shift assays</term>.</sentence>
<event uncertainty="doubtful" id="E8">
<type class="Binding" />
<theme idref="T9" />
<theme idref="A6" />
<clue>The <clueType>interaction</clueType> <linkTheme>of</linkTheme> the transcription factors, activator protein-1 (AP-1), nuclear factor kappa B (NF kappa B), and cAMP-responsive element binding protein (CREB) <linkTheme>with</linkTheme> DNA and glucocorticoid receptors (GR) was analyzed <clueLoc>in human peripheral blood mononuclear cells</clueLoc> <clueExperiment>by gel mobility shift assays</clueExperiment>.</clue>
</event>
<event uncertainty="doubtful" id="E9">
<type class="Binding" />
<theme idref="T11" />
<theme idref="A6" />
<clue>The <clueType>interaction</clueType> <linkTheme>of</linkTheme> the transcription factors, activator protein-1 (AP-1), nuclear factor kappa B (NF kappa B), and cAMP-responsive element binding protein (CREB) <linkTheme>with</linkTheme> DNA and glucocorticoid receptors (GR) was analyzed <clueLoc>in human peripheral blood mononuclear cells</clueLoc> <clueExperiment>by gel mobility shift assays</clueExperiment>.</clue>
</event>
<event uncertainty="doubtful" id="E10">
<type class="Binding" />
<theme idref="T13" />
<theme idref="A6" />
<clue>The <clueType>interaction</clueType> <linkTheme>of</linkTheme> the transcription factors, activator protein-1 (AP-1), nuclear factor kappa B (NF kappa B), and cAMP-responsive element binding protein (CREB) <linkTheme>with</linkTheme> DNA and glucocorticoid receptors (GR) was analyzed <clueLoc>in human peripheral blood mononuclear cells</clueLoc> <clueExperiment>by gel mobility shift assays</clueExperiment>.</clue>
</event>
<event uncertainty="doubtful" id="E11">
<type class="Binding" />
<theme idref="T9" />
<theme idref="T15" />
<clue>The <clueType>interaction</clueType> <linkTheme>of</linkTheme> the transcription factors, activator protein-1 (AP-1), nuclear factor kappa B (NF kappa B), and cAMP-responsive element binding protein (CREB) <linkTheme>with</linkTheme> DNA and glucocorticoid receptors (GR) was analyzed <clueLoc>in human peripheral blood mononuclear cells</clueLoc> <clueExperiment>by gel mobility shift assays</clueExperiment>.</clue>
</event>
<event uncertainty="doubtful" id="E12">
<type class="Binding" />
<theme idref="T11" />
<theme idref="T15" />
<clue>The <clueType>interaction</clueType> <linkTheme>of</linkTheme> the transcription factors, activator protein-1 (AP-1), nuclear factor kappa B (NF kappa B), and cAMP-responsive element binding protein (CREB) <linkTheme>with</linkTheme> DNA and glucocorticoid receptors (GR) was analyzed <clueLoc>in human peripheral blood mononuclear cells</clueLoc> <clueExperiment>by gel mobility shift assays</clueExperiment>.</clue>
</event>
<event uncertainty="doubtful" id="E13">
<type class="Binding" />
<theme idref="T13" />
<theme idref="T15" />
<clue>The <clueType>interaction</clueType> <linkTheme>of</linkTheme> the transcription factors, activator protein-1 (AP-1), nuclear factor kappa B (NF kappa B), and cAMP-responsive element binding protein (CREB) <linkTheme>with</linkTheme> DNA and glucocorticoid receptors (GR) was analyzed <clueLoc>in human peripheral blood mononuclear cells</clueLoc> <clueExperiment>by gel mobility shift assays</clueExperiment>.</clue>
</event>
<sentence id="S4"><cons sem="(AND Other Other)" id="T18" lex="(AND TNF-alpha,_IL-1_beta__treatment phorbol_myristate_acetate_(PMA)_treatment)"><frag id="F4"><term sem="Protein_molecule" id="A7">TNF-alpha</term></frag>, <frag id="F5"><term sem="Protein_molecule" id="A8">IL-1 beta</term></frag> and <frag id="F6">phorbol myristate acetate (<term sem="Organic_compound_other" id="A9">PMA</term>)</frag> <frag id="F7">treatment</frag></cons> increased <term sem="Protein_molecule" id="T19" lex="AP-1">AP-1</term> and <term sem="Protein_family_or_group" id="A111">NF kappa B</term> <term sem="DNA_domain_or_region" id="A10">DNA</term> binding by up to 200% but decreased <term sem="Other" id="T20" lex="CREB_binding"><term sem="Protein_molecule" id="T21" lex="CREB">CREB</term> binding</term> (38%) over a 60-min time course.</sentence>
<event id="E17">
<type class="Binding" />
<theme idref="T19" />
<theme idref="A10" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment increased AP-1 and NF kappa B DNA <clueType>binding</clueType> by up to 200% but decreased CREB binding (38%) over a 60-min time course.</clue>
</event>
<event id="E18">
<type class="Binding" />
<theme idref="T19" />
<theme idref="A111" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment increased AP-1 and NF kappa B DNA <clueType>binding</clueType> by up to 200% but decreased CREB binding (38%) over a 60-min time course.</clue>
</event>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="E17" />
<cause idref="A7" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment <clueType>increased</clueType> AP-1 and NF kappa B DNA binding by up to 200% but decreased CREB binding (38%) over a 60-min time course.</clue>
</event>
<event id="E20">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="A7" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment <clueType>increased</clueType> AP-1 and NF kappa B DNA binding by up to 200% but decreased CREB binding (38%) over a 60-min time course.</clue>
</event>
<event id="E21">
<type class="Positive_regulation" />
<theme idref="E17" />
<cause idref="A8" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment <clueType>increased</clueType> AP-1 and NF kappa B DNA binding by up to 200% but decreased CREB binding (38%) over a 60-min time course.</clue>
</event>
<event id="E22">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="A8" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment <clueType>increased</clueType> AP-1 and NF kappa B DNA binding by up to 200% but decreased CREB binding (38%) over a 60-min time course.</clue>
</event>
<event id="E23">
<type class="Positive_regulation" />
<theme idref="E17" />
<cause idref="A9" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment <clueType>increased</clueType> AP-1 and NF kappa B DNA binding by up to 200% but decreased CREB binding (38%) over a 60-min time course.</clue>
</event>
<event id="E201">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="A9" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment <clueType>increased</clueType> AP-1 and NF kappa B DNA binding by up to 200% but decreased CREB binding (38%) over a 60-min time course.</clue>
</event>
<event id="E24">
<type class="Binding" />
<theme idref="T21" />
<theme idref="A10" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment increased AP-1 and NF kappa B DNA binding by up to 200% but decreased CREB <clueType>binding</clueType> (38%) over a 60-min time course.</clue>
</event>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="A7" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment increased AP-1 and NF kappa B DNA binding by up to 200% but <clueType>decreased</clueType> CREB binding (38%) over a 60-min time course.</clue>
</event>
<event id="E26">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="A8" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment increased AP-1 and NF kappa B DNA binding by up to 200% but <clueType>decreased</clueType> CREB binding (38%) over a 60-min time course.</clue>
</event>
<event id="E27">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="A9" />
<clue>TNF-alpha, IL-1 beta and phorbol myristate acetate (PMA) treatment increased AP-1 and NF kappa B DNA binding by up to 200% but <clueType>decreased</clueType> CREB binding (38%) over a 60-min time course.</clue>
</event>
<sentence id="S5"><term sem="Lipid" id="T22" lex="dexamethasone">Dexamethasone</term> produced a rapid and sustained increase in <term sem="Other" id="T23" lex="glucocorticoid_response_element_binding"><term sem="DNA_domain_or_region" id="T24" lex="glucocorticoid_response_element">glucocorticoid response element</term> binding</term> and a concomitant 40-50% decrease in <cons sem="(AND Other Other Other)" id="T25" lex="(AND AP-1_DNA_binding NF_kappa_B_DNA_binding CREB_DNA_binding)"><frag id="F8"><term sem="Protein_molecule" id="A11">AP-1</term></frag>, <frag id="F9"><term sem="Protein_family_or_group" id="A12">NF kappa B</term></frag>, and <frag id="F10"><term sem="Protein_family_or_group" id="A114">CREB</term></frag> <frag id="F11"><term sem="DNA_domain_or_region" id="A13">DNA</term> binding</frag></cons> that was blocked by combined <term sem="Lipid" id="T26" lex="dexamethasone">dexamethasone</term> and <term sem="Protein_family_or_group" id="T27" lex="cytokine"><term sem="Other" id="T28" lex="cytokine_treatment">cytokine</term></term> or <term sem="Other" id="T29" lex="PMA_treatment"><term sem="Organic_compound_other" id="A14">PMA</term> treatment</term>.</sentence>
<event id="E28">
<type class="Binding" />
<theme idref="T24" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element <clueType>binding</clueType> and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA binding that was blocked by combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E29">
<type class="Positive_regulation" />
<theme idref="E28" />
<cause idref="T22" />
<clue>Dexamethasone produced a rapid and sustained <clueType>increase</clueType> <linkTheme>in</linkTheme> glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA binding that was blocked by combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E30">
<type class="Binding" />
<theme idref="A11" />
<theme idref="A13" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA <clueType>binding</clueType> that was blocked by combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E31">
<type class="Binding" />
<theme idref="A12" />
<theme idref="A13" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA <clueType>binding</clueType> that was blocked by combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E32">
<type class="Binding" />
<theme idref="A114" />
<theme idref="A13" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA <clueType>binding</clueType> that was blocked by combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E33">
<type class="Negative_regulation" />
<theme idref="E30" />
<cause idref="T22" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% <clueType>decrease</clueType> <linkTheme>in</linkTheme> AP-1, NF kappa B, and CREB DNA binding that was blocked by combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E100">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="T22" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% <clueType>decrease</clueType> <linkTheme>in</linkTheme> AP-1, NF kappa B, and CREB DNA binding that was blocked by combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E101">
<type class="Negative_regulation" />
<theme idref="E32" />
<cause idref="T22" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% <clueType>decrease</clueType> <linkTheme>in</linkTheme> AP-1, NF kappa B, and CREB DNA binding that was blocked by combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E34">
<type class="Binding" />
<theme idref="T26" />
<theme idref="T28" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA binding that was blocked by <clueType>combined</clueType> dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E35">
<type class="Negative_regulation" />
<theme idref="E30" />
<cause idref="E34" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA binding that was <clueType>blocked</clueType> <linkTheme>by</linkTheme> combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E36">
<type class="Negative_regulation" />
<theme idref="E30" />
<cause idref="A14" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA binding that was <clueType>blocked</clueType> <linkTheme>by</linkTheme> combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E202">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="E34" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA binding that was <clueType>blocked</clueType> <linkTheme>by</linkTheme> combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E203">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="A14" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA binding that was <clueType>blocked</clueType> <linkTheme>by</linkTheme> combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E204">
<type class="Negative_regulation" />
<theme idref="E32" />
<cause idref="E34" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA binding that was <clueType>blocked</clueType> <linkTheme>by</linkTheme> combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<event id="E205">
<type class="Negative_regulation" />
<theme idref="E32" />
<cause idref="A14" />
<clue>Dexamethasone produced a rapid and sustained increase in glucocorticoid response element binding and a concomitant 40-50% decrease in AP-1, NF kappa B, and CREB DNA binding that was <clueType>blocked</clueType> <linkTheme>by</linkTheme> combined dexamethasone and cytokine or PMA treatment.</clue>
</event>
<sentence id="S6">These latter effects were due to increases in the <term sem="Other" id="T30" lex="nuclear_localization">nuclear localization</term> of <term sem="Protein_family_or_group" id="T31" lex="GR">GR</term>, not to reduced amounts of the <term sem="Protein_family_or_group" id="A15">other <term sem="Protein_family_or_group" id="T32" lex="transcription_factor">transcription factors</term></term>.</sentence>
<event id="E37">
<type class="Localization" />
<theme idref="T31" />
<clue>These latter effects were due to increases in the <clueLoc>nuclear</clueLoc> <clueType>localization</clueType> <linkTheme>of</linkTheme> GR, not to reduced amounts of the other transcription factors.</clue>
</event>
<event id="E38">
<type class="Positive_regulation" />
<theme idref="E36" />
<clue>These latter effects were due to <clueType>increases</clueType> <linkTheme>in</linkTheme> the nuclear localization of GR, not to reduced amounts of the other transcription factors.</clue>
</event>
<event id="E39">
<type class="Correlation" />
<theme idref="E37" />
<theme idref="E33" />
<clue><corefTheme>These latter effects</corefTheme> were <clueType>due</clueType> <linkTheme>to</linkTheme> increases in the nuclear localization of GR, not to reduced amounts of the other transcription factors.</clue>
</event>
<event id="E40">
<type class="Correlation" />
<theme idref="E37" />
<theme idref="E100" />
<clue><corefTheme>These latter effects</corefTheme> were <clueType>due</clueType> <linkTheme>to</linkTheme> increases in the nuclear localization of GR, not to reduced amounts of the other transcription factors.</clue>
</event>
<event id="E41">
<type class="Correlation" />
<theme idref="E37" />
<theme idref="E101" />
<clue><corefTheme>These latter effects</corefTheme> were <clueType>due</clueType> <linkTheme>to</linkTheme> increases in the nuclear localization of GR, not to reduced amounts of the other transcription factors.</clue>
</event>
<event id="E42">
<type class="Negative_regulation" />
<theme idref="A15" />
<clue>These latter effects were due to increases in the nuclear localization of GR, not to <clueType>reduced</clueType> amounts of the other transcription factors.</clue>
</event>
<event assertion="non-exist" id="E43">
<type class="Correlation" />
<theme idref="E40" />
<theme idref="E39" />
<clue><corefTheme>These latter effects</corefTheme> were <clueType>due</clueType> to increases in the nuclear localization of GR, not <clueType>to</clueType> reduced amounts of the other transcription factors.</clue>
</event>
<sentence id="S7">This suggests that in these cells <term sem="Protein_family_or_group" id="T33" lex="GR">GR</term> within the <term sem="Cell_component" id="T34" lex="nucleus">nucleus</term> interacts with <term sem="Protein_family_or_group" id="T35" lex="cytokine-stimulated_transcription_factor"><term sem="Protein_family_or_group" id="T36" lex="cytokine">cytokine</term>-stimulated <term sem="Protein_family_or_group" id="T37" lex="transcription_factor">transcription factors</term></term> by the process of cross coupling.</sentence>
<event id="E44">
<type class="Binding" />
<theme idref="T33" />
<theme idref="T35" />
<clue>This suggests that <clueLoc>in these cells</clueLoc> GR <clueLoc>within the nucleus</clueLoc> <clueType>interacts</clueType> <linkTheme>with</linkTheme> cytokine-stimulated transcription factors by the process of cross coupling.</clue>
</event>
<sentence id="S8">This may be an important molecular site of <term sem="Lipid" id="T38" lex="steroid">steroid</term> action.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
